Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$3/mo
Lower than 95% of peersNiche median $19/mo
Creators
Rohan J. Dani
No social account linked
Launched
13d ago
2026-11-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Bringing back newspapers like it's the 1990s

    Nov 3 · 13d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

The complete Less is More
$3/mo
Billed annually $36/yr

Trial: Your first 14 days are free. · 1 paid tier ($3) · Observed 2026-11-08 · Source page

Entry price $3/mo, Lower than 95% of peers; “Financial Data & Research” median is $19/mo.View pricing benchmark

Pages & changes

Tracked since 2026-11-03

Key pages

Weekly snapshots
Home
lessismore.media/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Less is More cost?
The complete Less is More: $3/mo (annual billing available). Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Less is More get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Less is More and what platforms does it support?
Less is More is catalogued under Financial Data & Research: Your personalized newspaper. Supported platforms: Web.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.